Main Page
Faculty Deanship
Dean
Health Empowerment Unit
Strategic Planning Unit
Development and Quality Unit
Medical and Bioethics Unit
Vice Dean for Graduate Studies and Research
Vice Dean for Female Section
Vice dean for Academic Affairs
Examination and Assessment Unit
Internship and Alumni Unit
Student Research Unit
E-learning Unit
Student Mentoring and Support Unit
Community Service Unit
Talent and Creativity Care Unit
Continuing Education Unit
Neuroscience Research Unit
Vice Deanship of Clinical Affairs / Administration
Organizational Structure
Departments
Basic Sciences
Department of Anatomy
Department of Pharmacology
Department of Pathology
Department of Microbiology and Medical Parasitolog
Deparment of Clinical Biochemistry
Department of Physiology
Department of Medical Genetics
Clinical Sciences
Department of Otorhinolaryngology
Department of Obstetrics and Gynecology
Department of Hematology
Department of Medical Education
Department of Anesthesia
Department of Family Medicine
Department of Community Medicine
Department of Surgery
Department of Orthopedic Surgery
Department of ophthalmology
Department of Radiology
Department of Internal Medicine
Department of Pediatrics
Department of Emergency Medicine
Department of Urology
Department of Dermatology
Latest News
عربي
English
About
Admission
Academic
Research and Innovations
University Life
E-Services
Search
Faculty of Medicine
Document Details
Document Type
:
Article In Journal
Document Title
:
Prostate Cancer: An update on the recent advances in the diagnosis and management with special reference to Saudi Arabia
Prostate Cancer: An update on the recent advances in the diagnosis and management with special reference to Saudi Arabia
Subject
:
Urology
Document Language
:
English
Abstract
:
In recent years, there has been a major change in the presentation of the Cancer of the Prostate gland (CaP) in the industrially developed countries. Currently, in those countries CaP patients present in a new early preclinical stage designated only recently in 1992 as stage T1c. The two main factors behind this change are: the advent of Prostatic Specific Antigen (PSA) and the increased prosperity with the associated prolonged longevity. Currently, PSA is recognised as the most sensitive tumor marker widely used for CaP initial screening and for tumor monitoring. The other factor yielded to the recently noted rise the annual prevalence rates of CaP is that the male population nowadays live to ages at which the incidence of CaP peaks.Over the past two decades, CaP has been the most frequently diagnosed cancer in the American and the second most common in European men. The rates are progressively increasing. But this is not the case for eastern countries so far, especially in Saudi Arabia. On the contrary, this article will show that this cancer is still not frequently diagnosed in Saudi Arabia, a great opportunity for us to study its natural history and plan for preventive measures. Stage T1c of the prostate is a pre-clinical biopsy diagnosed cancer based upon PSA-screening. The only part of Saudi Arabia where patients commonly present in this stage is the industrially advanced ARAMCO community. In that community only, not in the whole Eastern province, dwelling elderly men are regularly screened annually by PSA testing for prostate cancer. Most of the CaP patients in the rest of Saudi Arabia present at the other later stages of the disease
ISSN
:
1319-1004
Journal Name
:
Medical Science Journal
Volume
:
8
Issue Number
:
1
Publishing Year
:
1420 AH
2000 AD
Article Type
:
Article
Added Date
:
Friday, April 1, 2011
Researchers
Researcher Name (Arabic)
Researcher Name (English)
Researcher Type
Dr Grade
Email
هشام موصلي
Mosli, Hisham
Researcher
Doctorate
Files
File Name
Type
Description
29476.pdf
pdf
Back To Researches Page